Health Insurance Premiums - Research and Data from KFF

How Would Drug Price Negotiation Affect Medicare Part D Premiums?

Aug 12, 2021

Issue Brief

Proposals to allow the federal government to negotiate prescription drug prices, such as H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, aim to lower out-of-pocket drug costs for Medicare beneficiaries and private plan enrollees and achieve savings for Medicare. This data note estimates average premium savings attributable to the negotiations provision of H.R. 3 on a per capita basis for Part D enrollees who pay premiums in dollar amounts and as a…

Understanding the Impact of Medicaid Premiums & Cost-Sharing: Updated Evidence from the Literature and Section 1115 Waivers

Sep 9, 2021

Issue Brief

Our review of recent literature on premiums and cost-sharing is based on studies and reports published between 2017 and 2021. Our analysis of premiums in post-Affordable Care Act (ACA) Section 1115 waivers (approved under the Obama and Trump administrations) is based on available interim and final waiver evaluations as well as annual and quarterly state data reports posted on Medicaid.gov.

Nov. 10 Web Briefing to Release the 2021 Employer Health Benefits Survey Capturing Trends in Offer Rate, Premiums, Cost Sharing and Benefit Changes Related to COVID-19

Event Date: Nov 10, 2021

Event

KFF released its 2021 benchmark Employer Health Benefits Survey via a public web briefing on Nov. 10, 2021. This 23rd annual survey provided a detailed look at the current state of employer-based coverage and trends in private health insurance for both large and small firms. Fielded among a nationally representative sample of nearly 1,700 employers with at least three workers, the survey captures average premiums for workers and employers and their rate of increase; average…

Medicare Part D: A First Look at Medicare Prescription Drug Plans in 2022

Nov 2, 2021

Issue Brief

This issue brief provides an overview of the Medicare Part D prescription drug benefit market for 2022, with a primary focus on stand-alone drug plans. It includes national and state-level data on plan availability, premiums, benefit design, cost sharing, information about premium-free plans for low-income beneficiaries, and information about the national Part D drug plans available in 2022.

How the American Rescue Plan Act Affects Subsidies for Marketplace Shoppers and People Who Are Uninsured

Mar 25, 2021

Issue Brief

This brief uses data from the American Community Survey (ACS) to provide estimates of eligibility for and the amount of financial assistance to purchase Marketplace coverage under the ARPA among both current individual market purchasers, as well as Marketplace-eligible uninsured people.

Analysis Estimates 5.1 Million People Fall into the Affordable Care Act’s “Family Glitch”

Apr 7, 2021

News Release

A new KFF analysis estimates 5.1 million people nationally fall into the Affordable Care Act’s “family glitch” that occurs when a worker receives an offer of affordable employer coverage for themselves but not for their dependents, making them ineligible for financial assistance for marketplace coverage. The so-called glitch occurs because the ACA prohibits people with an offer of affordable employer coverage from purchasing subsidized coverage through the ACA marketplace. Under current rules, the affordability of…

Private Insurers Are Expected to Pay $2.1 Billion in Rebates to Consumers This Year for Excessive Health Insurance Premiums Relative to Health Care Expenses

Apr 12, 2021

News Release

Private insurance companies are expecting to pay out $2.1 billion in rebates to consumers this fall, the second highest amount ever issued under the Affordable Care Act, according to a new KFF analysis. The rebates, which are calculated based on the share of premium revenues that insurance companies paid out for health care expenses and quality improvement, are roughly $400 million lower than last year’s record high of $2.5 billion, but more than 50 percent…

Although Their Share of the Market Varies By State, Enrollment in Medicare Advantage Plans Has More Than Doubled Over the Past Decade, with More than 4 in 10 Medicare Beneficiaries Now Enrolled in the Private Plans

Jun 21, 2021

News Release

The private plans known as Medicare Advantage now cover more than 4 in 10 Medicare beneficiaries, reflecting a more than doubling of enrollment over the past decade even as the plans remain a far larger presence in some states than others, according to a new KFF analysis. More than 26 million of the nation’s nearly 63 million Medicare beneficiaries are enrolled in Medicare Advantage plans in 2021. The share varies considerably by state, ranging from…

Medicare Part D: A First Look at Prescription Drug Plans in 2017

Oct 17, 2016

Issue Brief

This issue brief provides an overview of the 2017 Medicare Part D stand-alone prescription drug plan marketplace, based on analysis of data from the Centers for Medicare & Medicaid Services. The brief focuses on data for 2017 and changes over time in plan availability, premiums, benefit design, cost sharing, and low-income subsidy plan availability.

5 things to know about Obamacare’s (likely) premium hikes

May 11, 2016

Perspective

In this guest column for VOX, the Kaiser Family Foundation's Larry Levitt examines several key factors behind the expected premium rate increases for the Affordable Care Act's marketplace plans in 2017 and what they mean for the stability of the marketplace.

Topics

Policy Research

Polling

Health News

Data & Features

For Media

About

View the Latest: Premiums

Filter